Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11.55M | $122.0M | 33.62% | -- | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 2.88M | $30.0M | 8.37% | -35.3K | 2026-03-31 |
| FRANKLIN RESOURCES INC | 2.38M | $25.0M | 6.92% | +180.9K | 2026-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.12M | $22.0M | 6.17% | -- | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 1.85M | $19.0M | 5.39% | -- | 2026-03-31 |
| Nantahala Capital Management, LLC | 1.44M | $15.0M | 4.19% | +400.0K | 2026-03-31 |
| BlackRock, Inc. | 1.19M | $12.0M | 3.45% | +193.4K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 931.6K | $9.0M | 2.71% | -- | 2026-03-31 |
| INFINITUM ASSET MANAGEMENT, LLC | 923.0K | $9.0M | 2.69% | +24.1K | 2026-03-31 |
| Alyeska Investment Group, L.P. | 750.0K | $7.0M | 2.18% | -- | 2026-03-31 |
